Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
Cancers|May 25, 2024
Characterization of FOLH1 Expression in Renal Cell CarcinomaEric Ovruchesky, Elizabeth Pan, Melis Guer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2026
Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 CasesCésar Serrano, Andrew Elliott, David Gómez-Peregrina, et al.
JCO Precision Oncology|October 24, 2024
Multiomic Characterization and Molecular Profiling of Nuclear Protein in Testis CarcinomaGianna Kroening, Jia Luo, Mark G Evans, et al.
Cancer|February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunitiesSonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Cancer Cell|November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activationDavid Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Frontiers in Oncology|May 11, 2023
ERBB family fusions are recurrent and actionable oncogenic targets across cancer typesLaura Schubert, Andrew Elliott, Anh T Le, et al.
Nature|September 17, 2025
Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancerAbbie S Ireland, Daniel A Xie, Sarah B Hawgood, et al.
International Journal of Molecular Sciences|June 26, 2025
HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial CancersNikitha Vobugari, Allison Makovec, Samuel Kellen, et al.
The Journal of Clinical Investigation|April 23, 2024
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profilesPedro Barata, Shuchi Gulati, Andrew Elliott, et al.
ESMO Open|November 24, 2020
Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinomaAndreas Seeber, Kai Zimmer, Florian Kocher, et al.
Pageof 20